> top > docs > PMC:7386875 > spans > 1563-1841 > annotations

PMC:7386875 / 1563-1841 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T9 124-131 Body_part denotes heparin http://purl.org/sig/ont/fma/fma82839

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T26 82-90 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T27 102-112 Disease denotes thrombosis http://purl.obolibrary.org/obo/MONDO_0000831

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T2 23-28 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T3 124-131 Chemical denotes heparin http://purl.obolibrary.org/obo/CHEBI_28304
T4 138-148 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T5 163-168 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T6 170-180 Chemical denotes nafamostat http://purl.obolibrary.org/obo/CHEBI_135466
T7 186-198 Chemical denotes dipyridamole http://purl.obolibrary.org/obo/CHEBI_4653
T8 260-269 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T10 0-278 Sentence denotes Several antithrombotic drugs have been proposed as potential therapies to prevent COVID-19-associated thrombosis, including heparin, FXII inhibitors, fibrinolytic drugs, nafamostat, and dipyridamole, many of which also possess pleiotropic anti-inflammatory or antiviral effects.

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
57 124-131 Chemical denotes heparin MESH:D006493
58 170-180 Chemical denotes nafamostat MESH:C032855
59 186-198 Chemical denotes dipyridamole MESH:D004176
85 82-90 Disease denotes COVID-19 MESH:C000657245
86 102-112 Disease denotes thrombosis MESH:D013927